Greg Jensen
2020
In 2020, Greg Jensen earned a total compensation of $861.1K as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $108,469 |
| Salary | $402,462 |
| Stock Awards | $107,557 |
| Other | $72,616 |
| Total | $861,104 |
Jensen received $402.5K in salary, accounting for 47% of the total pay in 2020.
Jensen also received $170K in non-equity incentive plan, $108.5K in option awards, $107.6K in stock awards and $72.6K in other compensation.
Rankings
In 2020, Greg Jensen's compensation ranked 9,211th out of 13,090 executives tracked by ExecPay. In other words, Jensen earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,211 out of 13,090 | 30th |
Division Manufacturing | 3,935 out of 5,621 | 30th |
Major group Chemicals And Allied Products | 1,597 out of 2,254 | 29th |
Industry group Drugs | 1,396 out of 1,954 | 29th |
Industry Biological Products, Except Diagnostic Substances | 327 out of 411 | 20th |
Source: SEC filing on June 14, 2021.
Jensen's colleagues
We found two more compensation records of executives who worked with Greg Jensen at Xtant Medical Holdings in 2020.